MEI Pharma, Inc. - Special Call

14/4/2020 8:00

Conference Call MEI Pharma Inc

MEI Pharma Inc Conference call or earnings call will be held on Apr 14, 2020 via an 800 number (toll-free). During the earnings conference call's session MEI Pharma Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact MEI Pharma Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are an oncology company focused on the clinical development of novel therapies for cancer. Our common stock is listed on the Nasdaq Capital Market under the symbol "MEIP". Our business purpose is the development of drugs for the treatment of cancer. Our portfolio of drug candidates includes Pracinostat, an oral histone deacetylase ("HDAC") inhibitor being developed in combination with azacitidine for the treatment of patients with newly diagnosed acute myeloid leukemia ("AML") who are ³75 years of age or unfit for intensive chemotherapy and high-risk myelodysplastic syndrome ("MDS"). In August 2016, we entered into an exclusive worldwide license, development and commercialization agreement with Helsinn Healthcare SA ("Helsinn") for Pracinostat in AML and other potential indications.    
Read more Conference Call

MEI Pharma Inc (MEIP)

11975 El Camino Real, San Diego California 92130, United States